CVS Health Corporation

CVS
  • CVS Healthcare declined 7.5% to $58.90 after the drugstore chain announced preliminary third quarter earnings and replaced its chief executive. 

    The company estimated diluted earnings per share to range between 3 cents and 8 cents and adjusted earnings per share between $1.05 and $1.10. 

    The company appointed longtime executive David Joyner as the new chief executive and president, replacing Karen Lynch effective October 17. 

    The drug retailer said it plans to take a restructuring charge of $1.2 billion in the third quarter, related to incremental store closure costs and previously disclosed cost reduction actions. 
    Oct 18, 2024

  • CVS Health Corp decreased 9.5% to $66.10 after Blue Shield of California dropped the company's pharmacy services. 

    The company said it will partner with Cost Plus Drug Company and Amazon pharmacy services to save drug costs for its 5 million members. 
    Aug 17, 2023

    $ 77.93
  • 1.27 % 0.98
  • Last Close
  • Feb 12, 2026

Trading Volume 409,108
  • 52-Week High/Low ($)
  • 81.39 - 53.57
    Market Cap Full $ 73.3B
    Quarterly +
    2026 2025 2024 2023
    Q1 -1% 50.9% 1% -20.3%
    Q2 - 1.8% -20.9% -7%
    Q3 - 9.3% 11.2% 1%
    Q4 - 5.3% -30.6% 13.3%
    Monthly +
    J F M A M J J A S O N D
    2026
    0.9 - - - - - - - - - - -
    2025
    25.9 16.3 3 -1.6 -4 7.7 -10 17.8 3.1 3.7 2.8 -1.3
    2024
    -5.8 -0.1 7.3 -15.2 -11.9 -0.8 2 -5 13.1 -12.9 5.7 -24.7
    2023
    -5.4 -5.3 -11.1 -1.3 -7.1 1.5 8.1 -12.7 7.1 -1.2 -1.6 16.2
    2022
    2.1 -1.9 -2.4 -3.9 -0.5 -4.2 3.3 3.3 -3.5 -0.7 7.6 -8.5
    2021
    4.9 -4.7 11.3 0.6 13.8 -4.1 -0.9 4.4 -1.8 5.2 1.4 14.4
    Annually +
    2026 2025 2024 2023 2022
    CVS -2%77%-43%-15%-10%

    EPS
    2023 2022 2021
    Q1 1.7 1.7 1.7
    Q2 1.5 2.2 2.1
    Q3 1.8 -2.6 1.2
    Q4 0 1.8 1
    A 4.88 3.14 6
    52 Week High/Low
    Quarterly EPS
    Annual EPS
    Stock Price +
    Trading Volume


    Weekly Newsletter